產(chǎn)品描述: | FICZ (6-Formylindolo[3,2-b]carbazole) 是一種 aryl hydrocarbon receptor (AhR) 的有效激動(dòng)劑,可被AHR調(diào)節(jié)的細(xì)胞色素P4501酶有效地代謝 |
靶點(diǎn): |
AhR;ArylHydrocarbonReceptor |
體內(nèi)研究: |
FICZ improves the atopic dermatitis-like skin inflammation, clinical scores, and transepidermal water loss in NC/Nga mice compared with those of control mice. On histology, FICZ significantly reduces the epidermal and dermal thickness as well as the number of mast cells. Topical FICZ also significantly reduces the gene expression of Il22. |
細(xì)胞實(shí)驗(yàn): |
Cell lines: Human immortalized HaCaT cells, normal human epidermal keratinocytes (NHEKs) Concentrations: 1 nM, 10 nM, 100 nM Incubation Time: 1 h, 3 h, 5 h Method: HaCaTcells or NHEKs (1×104 cells/well) are platedon an 8-well μ-slide for 48 h, and treated with or without FICZ for 3 or 1 h, respectively. Then, the cells are washed with phosphate-buffered saline (PBS), fixed with acetone for 10 min, and blocked with 5% (w/v) bovine serum albumin in PBS for 30 min. The cells are then incubated with primary rabbit anti-AHR antibody (1:100) overnight at 4 ℃. Specific binding is detected using a horseradish peroxidase-conjugated goat anti-rabbit anti-body followed by tyramide labeling with green-fluorescent Alexa Fluor 488 for 1 h at room temperature in accordance with the manufacturer's instructions. |
動(dòng)物實(shí)驗(yàn): |
Animal Models: 9–10 week-old female NC/Nga mice Dosages: 100 mg/affected area Administration: Topical |
參考文獻(xiàn): |
1. Emma Wincent, et al. Biochem Pharmacol. 2016 Jun 15;110-111:117-29. 2. Mari Kiyomatsu-Oda, et al. J Dermatol Sci. 2018 Jun;90(3):284-294. |
溶解性: |
Soluble in DMSO |
保存條件: |
2-8℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
3.517 ml |
17.586 ml |
35.173 ml |
5 mM |
0.703 ml |
3.517 ml |
7.035 ml |
10 mM |
0.352 ml |
1.759 ml |
3.517 ml |
50 mM |
0.07 ml |
0.352 ml |
0.703 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。 |